All analyses

The Clorox Company (CLX) Stock Analysis

Score D

Value · Grade C · Bearish

Consumer Defensive · Household & Personal Products

$92.11

Fair Value

$31.63

-65.7%

Conviction

1/10

Quality

C

Classification

Value

Investment Thesis

Low quantitative score: Low quality, stretched valuation, or poor risk/reward.

For New Investors

Quantitative score: weak

For Current Holders

Quantitative score: low

Buy if

  • Price drops 15-20% (improves asymmetry)
  • Bull scenario catalysts materialize
  • Market-wide correction creates opportunity

Sell if

  • Bear scenario triggers occur
  • Quality metrics deteriorate (ROIC declining)
  • Better alternatives emerge

Valuation

Fair Value estimate: $31.63 (-65.7%). Overvalued vs fundamentals.

PEG-Based EPS

$13.80

FCF DCF Model

$13.08

Blended Fair Value

$31.63

Confidence

High

Methods

PEG-Based EPS, FCF 2-Stage DCF

Quality Analysis

C

64/120 points

Investable

ROE (3Y Avg)

5.5%

ROIC-WACC Spread

5.4%

D/E Ratio

0.5x

Current Ratio

0.9x

Interest Coverage

3x

FCF Positive Years

3/3

Quality Flags

  • Low ROE: 5.5% (need >12%, got 4/20 pts)
  • ROIC spread: 5.4pp (got 14/25 pts)
  • Leverage: D/E 0.5x (10/15 pts)
  • Interest coverage: 2.5x (8/10 pts)
  • Liquidity: Current Ratio 0.90 (8/10 pts)

Market Sentiment

Wall Street Consensus

$105.59

+14.6% Upside

17 analysts

Rating: Hold

Our model is more cautious than Wall Street.

Trend & Technical

Bearish

Price ($92.11) is 15.1% below SMA 200 ($108.54). Bearish trend. Caution on entry.

Technical Score46/100

Tech Score 46/100 — Weak technicals. Bearish bias in trend or momentum.

Risk & Reward

Asymmetry Ratio

0.95:1

Expected Return

-1.7%

Bull Upside

+20.9%

Bear Downside

-21.9%

Poor asymmetry: 0.95:1 ratio. Risk exceeds potential reward.

Verdict: Unfavorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of CLX?

Based on our multi-method conviction analysis, the estimated fair value of The Clorox Company (CLX) is $31.63. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is high.

Is CLX a buy, sell, or hold?

CLX currently has a AVOID rating with a conviction score of 1/10. Low quantitative score: Low quality, stretched valuation, or poor risk/reward. Quantitative score: weak.

Is CLX a high-quality stock?

The Clorox Company has a quality grade of C (64/120 points), rated as Investable. Key metrics include ROE of 5.5%, ROIC-WACC spread of 5.4%, and D/E ratio of 0.5x.

What type of stock is CLX?

CLX is classified as a "value" in our framework. Low P/E: 15.0x, High dividend: 5.3%, Mature growth: 0.0%, Consistent FCF: 3/3 years positive

What do Wall Street analysts say about CLX?

17 Wall Street analysts have a consensus price target of $105.59 for CLX, representing +14.6% upside. Targets range from — to —. The consensus recommendation is "Hold". Our model is more cautious than Wall Street.

What are the risks of investing in CLX?

The risk/reward asymmetry ratio for CLX is 0.95:1, rated as Unfavorable. Poor asymmetry: 0.95:1 ratio. Risk exceeds potential reward. The expected return is -1.7%, with bull case upside of +20.9% and bear case downside of -21.9%.

What is the current trend for CLX?

CLX is in a bearish trend. Price ($92.11) is 15.1% below SMA 200 ($108.54). Bearish trend. Caution on entry. The technical score is 46/100.

Related Stock Analyses

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.